Literature DB >> 7795588

Tissue-specific expression of a FMR1/beta-galactosidase fusion gene in transgenic mice.

M Hergersberg1, K Matsuo, M Gassmann, W Schaffner, B Lüscher, T Rülicke, A Aguzzi.   

Abstract

Fragile X syndrome is one of the most common genetic causes of mental retardation, yet the mechanisms controlling expression of the fragile X mental retardation gene FMR1 are poorly understood. To identify sequences regulating FMR1 transcription, transgenic mouse lines were established using a fusion gene consisting of an E.coli beta-galactosidase reporter gene (lacZ) linked to a 2.8 kb fragment spanning the 5'-region of FMR1. Five transgenic mouse lines showed lacZ expression in brain, in particular in neurons of the hippocampus and the granular layer of the cerebellum. Expression of the reporter gene was also detected in Leydig cells and spermatogonia in the testis, in many epithelia of adult mice, and in the two other steroidogenic cell types, adrenal cortex cells and ovarian follicle cells. Embryonic tissues which showed strong activity of the reporter gene included the telencephalon, the genital ridge, and the notochord. This expression pattern closely resembles the endogenous one, indicating that the 5' FMR1 gene promoter region used in this study contains most cis-acting elements regulating FMR1 transcription.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795588     DOI: 10.1093/hmg/4.3.359

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  17 in total

1.  Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin.

Authors:  F T Ruschitzka; R H Wenger; T Stallmach; T Quaschning; C de Wit; K Wagner; R Labugger; M Kelm; G Noll; T Rülicke; S Shaw; R L Lindberg; B Rodenwaldt; H Lutz; C Bauer; T F Lüscher; M Gassmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  Exploring the zebra finch Taeniopygia guttata as a novel animal model for the speech-language deficit of fragile X syndrome.

Authors:  Claudia Winograd; Stephanie Ceman
Journal:  Results Probl Cell Differ       Date:  2012

3.  Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes.

Authors:  Y Feng; C A Gutekunst; D E Eberhart; H Yi; S T Warren; S M Hersch
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

4.  Fragile-X: neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes.

Authors:  P Jäkälä; T Hänninen; M Ryynänen; M Laakso; K Partanen; A Mannermaa; H Soininen
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

5.  Characterization of FMR1 promoter elements by in vivo-footprinting analysis.

Authors:  S Schwemmle; E de Graaff; H Deissler; D Gläser; D Wöhrle; I Kennerknecht; W Just; B A Oostra; W Döerfler; W Vogel; P Steinbach; W Dörfler
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

6.  Chromosomal fragility and human genetic disorders.

Authors:  S Baskaran; V Brahmachari
Journal:  Indian J Clin Biochem       Date:  2000-08

7.  Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein.

Authors:  L Wan; T C Dockendorff; T A Jongens; G Dreyfuss
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

8.  Behavioral and neurochemical alterations in mice lacking the RNA-binding protein translin.

Authors:  Joel M Stein; Wayland Bergman; Yanshan Fang; Lakesha Davison; Colleen Brensinger; Michael B Robinson; Norman B Hecht; Ted Abel
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

9.  Expression of three zebrafish orthologs of human FMR1-related genes and their phylogenetic relationships.

Authors:  Ben Tucker; Robert Richards; Michael Lardelli
Journal:  Dev Genes Evol       Date:  2004-09-17       Impact factor: 0.900

Review 10.  Modeling neurodevelopmental disorders using human pluripotent stem cells.

Authors:  Michael Telias; Dalit Ben-Yosef
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.